Mediocre effects of reserpine on tardive dyskinesia. 1973

G E Crane

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G E Crane
January 1972, The New England journal of medicine,
G E Crane
May 1984, The American journal of psychiatry,
G E Crane
March 1972, The New England journal of medicine,
G E Crane
February 1983, The American journal of psychiatry,
G E Crane
January 1984, The American journal of psychiatry,
G E Crane
January 1989, Psychopharmacology bulletin,
G E Crane
January 1978, Transactions of the American Neurological Association,
G E Crane
April 1991, The British journal of psychiatry : the journal of mental science,
Copied contents to your clipboard!